Kamil Więcek, Piotr Kupczyk, Grzegorz Chodaczek, Marta Woźniak
Journal: Journal of immunology research 2022;2022():1208970
PMID: 35450396
Rheumatoid arthritis (RA) is one of the most prevalent autoimmune diseases, affecting approximately 1% of the total global population. Curcumin, a natural polyphenol is a substance that could potentially mitigate the course of this disease. To evaluate curcumin's anti-inflammatory impact on synoviocytes in the RA model, a set of experiments was conducted on SW982 cells, stimulated by IL-1, IL-6, or TNF- to emulate inflammation. During the research, the curcumin effect was evaluated by measuring cell survivability, expression of gene, subcellular localization of P70S6K1 protein, and its phosphorylated form and amount of produced IL-6 and TNF-. Results of conducted experiments presented a positive impact of curcumin on synoviocytes in the RA model, by reducing SW982 cells' survivability, decreasing levels of gene expression and TNF- protein production, which altogether confirm beneficial effects of the curcumin therapy in a RA model.
Copyright © 2022 Kamil Więcek et al.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.